Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

被引：0
|
作者：
van Mulligen, Elise [1 ,2 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands
[2] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands
来源：
LANCET RHEUMATOLOGY | 2024年 / 6卷 / 05期
关键词：
D O I：
10.1016/S2665-9913(24)00038-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e254 / e255
页数：2
相关论文
共 50 条
  • [31] A PROSPECTIVE STUDY OF TAPERING CONVENTIONAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS (C-DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN STABLE REMISSION
    Romi, Shah
    Balakrishnan, Canchi
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 370 - 371
  • [32] ADVERSE EVENTS RELATED TO CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rojas-Zuleta, Wilmer
    Becerra-Arias, Carolina
    Donado, Jorge
    Duque-Zapata, Natalia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S80 - S81
  • [33] DISTINCT CIRCULATING LYMPHOCYTE SUBSETS DISTINGUISH FLARE FROM DRUG-FREE REMISSION IN RHEUMATOID ARTHRITIS
    Baker, K. F.
    Rayner, F.
    Lemos, H.
    McDonald, D.
    Hulme, G.
    Hussain, R.
    Coxhead, J.
    Pratt, A.
    Anderson, A. E.
    Filby, A.
    Isaacs, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 50 - 51
  • [34] Response to: 'Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis' by Garcia et al
    van Mulligen, Elise
    de Jong, Pascal Hendrik Pieter
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01)
  • [35] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2018, 38 : 2225 - 2231
  • [36] On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Bykerk, Vivian P.
    Burmester, Gerd R.
    Combe, Bernard G.
    Furst, Daniel E.
    Huizinga, Tom W. J.
    Ahmad, Harris A.
    Emery, Paul
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (12) : 2225 - 2231
  • [37] Prevalence of and Predictive Factors for Sustained Disease-Modifying Antirheumatic Drug-Free Remission in Rheumatoid Arthritis Results From Two Large Early Arthritis Cohorts
    van der Woude, Diane
    Young, Adam
    Jayakumar, Keeranur
    Mertens, Bart J.
    Toes, Rene E. M.
    van der Heijde, Desiree
    Huizinga, Tom W. J.
    van der Helm-van Mil, Annette H. M.
    ARTHRITIS AND RHEUMATISM, 2009, 60 (08): : 2262 - 2271
  • [38] A combination model to predict relapse and successful conventional DMARDs de-escalation in rheumatoid arthritis patients with sustained clinical remission
    Wang, L.
    Geng, Y.
    Han, J.
    Sun, X.
    Zhang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (01) : 120 - 126
  • [39] Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
    Burkard, Theresa
    Williams, Ross D.
    Vallejo-Yaguee, Enriqueta
    Huegle, Thomas
    Finckh, Axel
    Kyburz, Diego
    Burden, Andrea M.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (03)
  • [40] Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission
    Baker, Kenneth F.
    Mcdonald, David
    Hulme, Gillian
    Hussain, Rafiqul
    Coxhead, Jonathan
    Swan, David
    Schulz, Axel R.
    Mei, Henrik E.
    Macdonald, Lucy
    Pratt, Arthur G.
    Filby, Andrew
    Anderson, Amy E.
    Isaacs, John D.
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345